Table I.
Target gene | Sequence |
---|---|
MMP-9 | F: 5′-CAAGCTGGACTCGGTCTTTGA-3′ |
R: 5′-TTCAACTCACTCCGGGAACTCA-3′ | |
PTX-3 | F: 5′-CATCCAGTGAGACCAATGAGG-3′ |
R: 5′-GTAGCCGCCAGTTCACCATTT-3′ | |
VEGF-α | F: 5′-CCACTGAGGAGTCCAACATCA-3′ |
R: 5′-CATTTACACGTCTGCGGATCTT-3′ | |
PlGF | F: 5′-ACTCAGCTCTTCTCCTCCTGTG-3′ |
R: 5′-ACGGTAATAAATACACGAGCCG-3′ | |
HIF-1α | F: 5′-AACCACCTATGACCTGCTTGGT-3′ |
R: 5′-TTGAGCGGCCTAAAAGTTCTTC-3′ | |
VHL | F: 5′-TACCGAGGTCACCTTTGGC-3′ |
R: 5′-GGAGGCATCGCTCTTTCAG-3′ | |
GAPDH | F: 5′-TCATGACCACAGTCCATGCC-3′ |
R: 5′-TCCACCACCCTGTTGCTGTA-3′ |
F, forward; R, reverse; MMP, matrix metalloprotein; PTX-3, pentraxin-related protein 3; VEGF, vascular endothelial growth factor; PlGF, placental growth factor; HIF, hypoxia-induciblefactor; VHL, von Hippell-Lindau protein.